Welcome to our dedicated page for Rcm Tech SEC filings (Ticker: RCMT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
RCM Technologies, Inc. filings document the reporting obligations of a Nevada-incorporated operating company with common stock registered on Nasdaq under the symbol RCMT. Its Form 8-K reports cover financial results, material agreements, revolving credit and loan amendments, direct financial obligations, changes in certifying accountants, and related internal control disclosures.
The company’s proxy materials address board matters, executive compensation, equity award information, and pay-versus-performance disclosure. Periodic and notice filings provide formal records around annual reporting, late-filing notifications, consolidated financial statements, risk and control matters, and the governance framework supporting RCM Technologies’ health care, engineering, information technology, life sciences, data, and solutions services.
RCM Technologies (RCMT) files a Form 144 reporting a proposed sale of 5,000 shares of common stock, with an aggregate market value of $137,500, to be sold approximately on 08/26/2025 on NASDAQ. The filing shows the shares were acquired through the company’s Employee Stock Purchase Plan on six dates between 2014 and 2022 and the listed acquisition lot quantities sum to 5,000 shares. No securities of the issuer were reported sold by the filer in the past three months. The notice includes the filer’s representation that they are not aware of undisclosed material adverse information about the issuer.